The Oncology Grand Rounds series is designed to place original reports published in the Journal into clinical context. A case presentation is followed by a description of diagnostic and management […]
Recent Content
- Antigen escape as a shared mechanism of resistance to BCMA-directed therapies in multiple myeloma
- The biological and clinical impact of deletions before and after large chromosomal gains in multiple myeloma
- Dr Jagannath on the Safety Considerations With CAR T-Cell Therapy Multiple Myeloma
- Identification of WNK1 as a therapeutic target to suppress IgH/MYC expression in multiple myeloma
- MYC Inhibition Potentiates CD8+ T Cells Against Multiple Myeloma and Overcomes Immunomodulatory Drug Resistance
- Early Detection of Precursor Diseases of Multiple Myeloma
- Unusual extramedullary presentation in newly diagnosed multiple myeloma: Synchronous infiltration of the maxillary sinus, thyroid, breast and bilateral ovaries
- Changes in income and employment after diagnosis among patients with multiple myeloma in The Netherlands
- Dr Ignatz-Hoover on Bispecific Antibodies in the Multiple Myeloma Treatment Armamentarium
- Erratum for the Research Article “Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma” by S. Manier et al